Target antidiabetic drug classes of interest were DPP-4i, BG, SU, α-GI, TZD, glinides, SGLT2i, insulin and GLP-1 receptor agonists and, in PT patients, were the five most common combinations of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback